[1]Torrisani J, Bournet B, Cordelier P, et al. New molecular targets in pancreatic cancer[J]. Bull Cancer, 2008,95(5):503-512.
[2]Taeger J, Moser C, Hellerbrand C, et al. Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer [J]. Mol Cancer Ther, 2011,10(11):2157-2167.
[3]Rahbari NN, Schmidt T, Falk CS, et al. Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer [J]. BMC Cancer, 2011,11:286.
[4]Yuzawa S, Kano MR, Einama T, et al. PDGFRβ expression in tumor stroma of pancreatic adenocarcinoma as a reliable prognostic marker [J]. Med Oncol, 2012, 29(4):2824-2830.
[5]Ilagan MX, Kopan R. SnapShot: notch signaling pathway [J]. Cell, 2007, 128(6):1246.
[6]Golde TE, Koo EH, Felsenstein KM, et al. γ-Secretase inhibitors and modulators [J]. Biochim Biophys Acta, 2013,1828(12):2898-2907.
[7]Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease [J]. Nat Rev Mol Cell Biol,2002,3(10):753-766.
[8]Capaccione KM, Pine SR. The Notch signaling pathway as a mediator of tumor survival [J]. Carcinogenesis, 2013,34(7):1420-1430.
[9]Ma YC, Shi C, Zhang YN, et al.The tyrosine kinase c-Src directly mediates growth factor-induced Notch-1 and Furin interaction and Notch-1 activation in pancreatic cancer cells [J]. PLoS One, 2012,7(3):e33414. |